top of page

The NanoOmics Platform Technology

We exploit the nanoparticle biomolecule corona formation in order to facilitate the comprehensive proteomic analysis of complex biological fluids. We employ nanoparticles as scavenging agents to uncover blood-buried molecular fingerprints of low abundance, otherwise “masked” under the overwhelming signal of highly abundant proteins (such as albumin and immunoglobulins). Our work has demonstrated that analysis of the biomolecule corona fingerprinting by mass spectrometry overcomes the critical ‘signal-to-noise’ hurdle and facilitates an in depth analysis of the blood circulation proteome. Our ultimate goal is to develop a nanoparticle-enabled integrative multi-omics blood analysis workflow.

The NanoOmics Platform Technology
Relevant Publications
4.png

Nanoscale

​The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids

Lana Papafilippou, Anna Nicolaou, Alexandra Kendall, Dolores Camacho-Muñoz, Marilena Hadjidemetriou*

4.png

Nanoscale Horizons

The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA​

Lois Gardner, Jessica Warrington, Jane Rogan, Dominic G. Rothwell, Ged Brady, Caroline Dive, Kostas Kostarelos*, Marilena Hadjidemetriou*

4.png

Nature Reviews Clinical Oncology

Nano-omics: Nanotechnology-based multidimensional harvesting of the blood-circulating cancerome

Lois Gardner, Kostas Kostarelos, Parag Mallick, Caroline Dive and Marilena Hadjidemetriou*

Funding & Collaborators

PART OF

Geoff Jeff transparent_edited.png

CONTACT US

NanoOmics lab,

5th floor, AV Hill Building
The University of Manchester
Manchester, M13 9PL
United Kingdom

View current vacancies:

bottom of page